 |
|
Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away?
Yeon-Mok Oh
Tuberc Respir Dis. 2017;80(1):93-94. Published online 2016 Dec 30 DOI: https://doi.org/10.4046/trd.2017.80.1.93
|
|
Citations to this article as recorded by
 Asthma Management Considerations for the Otolaryngologist
Dhanya Asokumar, Amarbir S. Gill
Otolaryngologic Clinics of North America.2024; 57(2): 215. CrossRef National Development in the Use of Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease: Repeated Cross-Sectional Studies from 1998 to 2018
Allan Klitgaard, Rikke Ibsen, Jesper Lykkegaard, Ole Hilberg, Anders Løkke
Biomedicines.2024; 12(2): 372. CrossRef Risk for pneumonia requiring hospitalization or emergency room visit according to delivery device for inhaled corticosteroid/long-acting beta-agonist in patients with chronic airway diseases as real-world evidence
Ju-Hee Park, Yunjung Kim, Seongmi Choi, Eun Jin Jang, Jimin Kim, Chang-Hoon Lee, Jae-Joon Yim, Ho-il Yoon, Deog Kyeom Kim
Scientific Reports.2019;[Epub] CrossRef
|